Maravai LifeSciences Holdings, Inc.
Price Action
Technical Summary
STAGE 2 UPTRENDMaravai LifeSciences Holdings, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 94), indicating clear outperformance against the broad market. Earnings growth of 88% provides fundamental context to the price action. However, price is extended 24% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $5.56 | +6.52% | ABOVE |
| 50 SMA | $4.79 | +23.52% | ABOVE |
| 100 SMA | $4.01 | +47.61% | ABOVE |
| 150 SMA | $3.86 | +53.36% | ABOVE |
| 200 SMA | $3.69 | +60.23% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is MRVI in an uptrend right now?
MRVI has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, MRVI is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is MRVI overbought or oversold?
MRVI's RSI (14) is 65. The stock is in neutral territory, neither overbought nor oversold.
Is MRVI outperforming the market?
MRVI has a Relative Strength (RS) Rating of 94 out of 99. Yes, MRVI is a market leader, outperforming 94% of all stocks over the past 12 months.
Where is MRVI in its 52-week range?
MRVI is trading at $5.92, which is 90% of its 52-week high ($6.54) and 86% above its 52-week low ($1.99).
How volatile is MRVI?
MRVI has a Beta of 1.68 and 52-week volatility of 71%. It's more volatile than the S&P 500 - expect bigger swings.